Age-related macular degeneration (AMD) is a leading cause of blindness, affecting 200
million people worldwide. To identify genes that could be targeted for treatment, we created …

The risk of developing age-related macular degeneration (AMD) is influenced by genetic
background. In 2016, the International AMD Genomics Consortium (IAMDGC) identified 52 …

Background Long-term consumption of Western Diet (WD) is a well-established risk factor
for the development of cardiovascular disease (CVD); however, there is a paucity of studies …

Aims To evaluate the long-term functional and anatomical outcomes of neovascular age-
related macular degeneration (nvAMD) treated with intravitreal anti-vascular endothelial …

Background: Age-related macular degeneration (AMD) is a major global health problem as it
is the leading cause of irreversible loss of central vision in the aging population. Av-vascular …

Purpose: In genome-wide association studies (GWAS), X chromosome (ChrX) variants are
often not investigated. Sex-specific effects and ChrX-specific quality control (QC) are needed …

Anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) has been
FDA-approved in 2004, and since then has helped tens of thousands of patients worldwide …

Возрастная макулярная дегенерация (ВМД)–прогрессирующее заболевание,
характеризующееся поражением макулярной зоны (центральной зоны сетчатки в …

Conclusions: Looking at the number of blindness cases in highly developed countries
caused by AMD, every effort should be made to introduce effective treatment that at least …

Humans exhibit a diverse range of variations in complex traits including behaviors and
diseases. The trait variations within and between populations, also known as inter-individual …